| Symbol: |
NARG2
|
| Description: |
NMDA receptor regulated 2 [Source:HGNC Symbol;Acc:29885]
|
| Location: |
Chr15:60711808-60771359[-]
|
| CRmiRSNP:
~ Export ~
|
Records:null
| Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
| Compound:
~ Export ~
|
Records:216
| Gene |
Compound |
Gen_sig |
Exp_pattern |
| NARG2 |
NSC 109834 |
0.001 |
Down |
| NARG2 |
Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) |
0.012 |
Down |
| NARG2 |
Ethanesulfonic acid, compd. with 2-(2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenoxy)acetanilide (1:1) |
0.018 |
Down |
| NARG2 |
Ethanesulfonic acid, compd. with 4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)-m-hydrocinnamotoluidide (1:1) |
0.009 |
Down |
| NARG2 |
Ethanesulfonic acid, compd. with 2-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]acetanilide (1:1) |
0.017 |
Down |
| NARG2 |
TZT |
0.017 |
Down |
| NARG2 |
as-Triazine-3,5(2H,4H)-dione, 2-.beta.-D-ribofuranosyl-3-thio- |
0.004 |
Down |
| NARG2 |
NSC 16857 |
0.034 |
Down |
| NARG2 |
Bromocriptine methanesulfonate |
0.016 |
Down |
| NARG2 |
NSC 175296 |
0.02 |
Down |
| NARG2 |
NSC 18320 |
0.036 |
Down |
| NARG2 |
NSC 191393 |
0.028 |
Up |
| NARG2 |
NSC 212446 |
0.001 |
Down |
| NARG2 |
NSC 227265 |
0.034 |
Down |
| NARG2 |
Buclizine Hydrochloride |
0.044 |
Down |
Expression pattern: Sensitivity / Resistance
Total:15 Current:1
[First] [Prev] Next Last
|
| SNP:
~ Export ~
|
Records:73
Total:5 Current:1
[First] [Prev] Next Last
|
| miRNA:
~ Export ~
|
Records:2
| Gene |
Gen_transcript |
miRNA |
miR_location |
| NARG2 |
ENST00000261520 |
hsa-mir-181d |
Chr19:13985724-13985746[+] |
| NARG2 |
ENST00000261520 |
hsa-mir-183-5p |
Chr7:129414807-129414828[-] |
Total:1 Current:1
[First] [Prev] [Next] [Last]
|